Comparison of clinicopathological characteristics and long-term survival between patients with gallbladder adenosquamous carcinoma and pure gallbladder adenocarcinoma after curative-intent surgery: a single-center experience in China and a meta-analysis

被引:2
|
作者
Lv, Tian-Run [1 ]
Liu, Fei [1 ]
Liang, Zuo-Yu [2 ]
Zou, Rui-Qi [1 ]
Ma, Wen-Jie [1 ]
Hu, Hai-Jie [1 ]
Li, Fu-Yu [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Gen Surg, Div Biliary Tract Surg, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Sichuan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
gallbladder; adeno-squamous; squamous; carcinoma; cancer; CELL-CARCINOMA; SQUAMOUS-CELL; CANCER;
D O I
10.3389/fonc.2023.1116275
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveThe aim of the study was to evaluate the similarities and differences between gallbladder adenosquamous carcinoma (GBASC) and pure gallbladder adenocarcinoma (GBAC). MethodsPatients with GBASC and GBAC from 2010 to 2020 were analyzed in terms of clinicopathological features and long-term survival. Moreover, a meta-analysis was also performed for further validation. ResultsOur experience: A total of 304 patients with resected GBC were identified, including 34 patients with GBASC and 270 patients with GBAC. Patients with GBASC had a significantly higher preoperative CA199 level (P <0.0001), a significantly higher incidence of liver invasion (P <0.0001), a relatively larger tumor size (P = 0.060), and a significantly higher proportion of patients with T3-4 (P <0.0001) or III-IV disease (P = 0.003). A comparable R0 rate was obtained between two groups (P = 0.328). A significantly worse overall survival (OS) (P = 0.0002) or disease-free survival (DFS) (P = 0.0002) was observed in the GBASC. After propensity score matching, comparable OS (P = 0.9093) and DFS (P = 0.1494) were obtained. Clear margin (P = 0.001), node metastasis (P <0.0001), T stage (P <0.0001), and postoperative adjuvant chemoradiotherapy (P <0.0001) were independent prognostic factors for OS for the entire cohort. Adjuvant chemoradiotherapy had a survival benefit for patients with GBAC, while the survival benefit was still being validated in patients with GBASC. Meta-analysis: With our cohort incorporated, a total of seven studies involving 1,434 patients with GBASC/squamous carcinoma (SC) were identified. GBASC/SC shared a worse prognosis (P <0.00001) and more aggressive tumor biological features than GBAC. ConclusionGBASC/SC shared more aggressive tumor biological features and a much worse prognosis than those with pure GBAC.
引用
收藏
页数:11
相关论文
共 3 条
  • [1] Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy A bimodal distribution
    Fung, Andrew K. Y.
    Cheng, Nicole M. Y.
    Chong, Charing C. N.
    Lee, Kit-Fai
    Wong, John
    Cheung, Sunny Y. S.
    Lok, Hon-Ting
    Lai, Paul B. S.
    Ng, Kelvin K. C.
    MEDICINE, 2020, 99 (48) : E23358
  • [2] Long-Term Outcomes after D2 Gastrectomy for Early Gastric Cancer: Survival Analysis of a Single-Center Experience in China
    Wang, Zheng
    Ma, Li
    Zhang, Xing-Mao
    Zhou, Zhi-Xiang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (17) : 7219 - 7222
  • [3] The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience
    Agalar, C.
    Sokmen, S.
    Arslan, C.
    Altay, C.
    Basara, I
    Canda, A. E.
    Obuz, F.
    TECHNIQUES IN COLOPROCTOLOGY, 2020, 24 (04) : 301 - 308